AB
XLRN

Amalgamated Bank’s Acceleron Pharma XLRN Stock Holding History

Amalgamated Bank’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,554
Closed -$1.64M – 2201
2021
Q3 		$1.64M Sell
9,554
-581
-6% -$76K 0.01% 1017
2021
Q2 		$1.27M Buy
10,135
+762
+8% +$96.1K 0.01% 1167
2021
Q1 		$1.27M Sell
9,373
-788
-8% -$102K 0.05% 422
2020
Q4 		$1.3M Hold
10,161
– – 0.05% 398
2020
Q3 		$1.14M Buy
10,161
+871
+9% +$86.7K 0.05% 385
2020
Q2 		$885K Buy
9,290
+1,498
+19% +$144K 0.04% 475
2020
Q1 		$700K Sell
7,792
-199
-2% -$15.5K 0.02% 754
2019
Q4 		$424K Buy
7,991
+245
+3% +$11.2K 0.01% 1209
2019
Q3 		$306K Sell
7,746
-108
-1% -$4.68K 0.01% 1313
2019
Q2 		$323K Buy
7,854
+1,649
+27% +$68.3K 0.01% 1317
2019
Q1 		$289K Buy
6,205
+649
+12% +$28.5K 0.01% 1288
2018
Q4 		$242K Buy
+5,556
New +$278K 0.01% 1303
2018
Q3 		– Sell
-5,795
Closed -$281K – 1679
2018
Q2 		$281K Buy
+5,795
New +$211K 0.01% 1363
2018
Q1 		– Sell
-5,107
Closed -$217K – 1654
2017
Q4 		$217K Buy
+5,107
New +$192K 0.01% 1454

Amalgamated Bank's XLRN Position: Q4 2021 in Review

Amalgamated Bank sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 9,554 shares — an estimated $1.64M sold.

Amalgamated Bank first reported a position in XLRN in Q4 2017 and held it in 14 quarters. The position peaked at $1.64M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • Amalgamated Bank reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • Amalgamated Bank sold 9,554 Acceleron Pharma shares in Q4 2021, an estimated $1.64M.
  • Amalgamated Bank first reported a position in Acceleron Pharma in Q4 2017 and held it in 14 quarters.
  • Amalgamated Bank's Acceleron Pharma position peaked at $1.64M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Amalgamated Bank's 13F filing for Q4 2021, filed 15 Feb 2022.